Ultra-Rapid Test Helps Identify Cancerous Cells in Real Time

UR-ddPCR can measure the level of tumor cells in a tissue sample in only 15 minutes.

Article

Published: March 4, 2025

Isabel Ely, PhD

speaking with

Gilad Evrony, PhD

Credit: iStock

Surgical precision in brain tumor removal may soon be enhanced by genetic data, thanks to a new technology developed at NYU Langone Health. Ultra-rapid droplet digital PCR (UR-ddPCR) can identify cancer cell mutations in real time, delivering results in just 15 minutes with high sensitivity.

In this interview, Dr. Gilad Evrony discusses how UR-ddPCR compares to standard techniques, its current limitations and its potential to guide more informed surgical decisions. He also outlines how the technology could be adapted for use in other cancers and clinical settings.

Sponsored by

Meet the Author

Isabel Ely, PhD

Science Writer

Isabel is a Science Writer and Editor at Technology Networks . She holds a BSc in exercise and sport science from the University of Exeter, a MRes in medicine and health and a PhD in medicine from the University of Nottingham. Her doctoral research explored the role of dietary protein and exercise in optimizing muscle health as we age.

Interviewing

Gilad Evrony, PhD

Assistant Professor

Dr. Gilad Evrony is an assistant professor at NYU School of Medicine’s Center for Human Genetics and Genomics, and the Departments of Pediatrics and Neuroscience & Physiology. He received his undergraduate degree in brain and cognitive sciences from MIT and completed an MD and PhD at Harvard Medical School.

View this Article for FREE Now!

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.

Experiencing issues viewing the form? Click here to access an alternate version